Clinical studies recruiting near Kurume

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer
Phase 3 · Kurume University School of Medicine · National Cancer Center Hospital East · NCT04288999 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Kurume University Hospital · Daiichi Sankyo · NCT07022483 A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurr
Phase 2 · Kurume University Hospital · Yonsei University · NCT06023862 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Kurume University Hospital · Pfizer · NCT06758401 A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therap
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07378969 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Kurume University Hospital ( Site 2112) · Merck Sharp & Dohme LLC · NCT07216703 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Kurume University Hospital · Pfizer · NCT07144280 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Kurume University Hospital · Boehringer Ingelheim · NCT06531824 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Kurume University Hospital · Amgen · NCT07005128 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Kurume University Hospital · Boehringer Ingelheim · NCT07220083 Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome
Phase 3 · Kurume University Hospial · Shoichi Maruyama MD PhD · NCT05914155 Software as a Medical Device for the Treatment of Patients With PTSD
Phase 2/Phase 3 · Otsuka Medical Devices Co., Ltd. Japan · NCT06589505 Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Phase N/A · Kurume University Hospital · Novartis Pharmaceuticals · NCT04174157 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Kurume University Hospital /ID# 254900 · AbbVie · NCT04928846 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Japan Community Healthcare Organization Kurume General Hospi · BeOne Medicines · NCT07492641 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Kurume University Hospital · Bristol-Myers Squibb · NCT06561386 A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Phase 3 · Kurume University Hospital · Takeda · NCT05442567 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Kurume University Hospital ( Site 3105) · Merck Sharp & Dohme LLC · NCT03486873 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Kurume University Hospital · Boehringer Ingelheim · NCT06632457 Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
Phase 3 · Kurume University Hospital · Juntendo University · NCT05392764 A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVAT
Phase 3 · Zai Lab Site 10019 · Zai Lab (Shanghai) Co., Ltd. · NCT07218146 Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Kurume University Hospital ( Site 0920) · Merck Sharp & Dohme LLC · NCT06136624 Phase III Trial of Stage I Ovarian Cancer After Surgery
Phase 3 · Kurume University Hospital · Japanese Gynecologic Oncology Group · NCT04063527 A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' D
Phase 2 · Site Number - 4004 · Immunovant Sciences GmbH · NCT07018323 A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease
Phase 3 · Hoffmann-La Roche · NCT06998524 A Study of ASP3082 in Adults With Advanced Solid Tumors
Phase 1 · Kurume University Hospital · Astellas Pharma Inc · NCT05382559 A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Phase 3 · Kurume University Hospital ( Site 1615) · Merck Sharp & Dohme LLC · NCT07318558 A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD
Phase 3 · Kurume University Hospital · Takeda · NCT06405087

Look up another city

Look up another condition